亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

武漢大華偉業(yè)醫(yī)藥化工有限公司供應(yīng)部  

醫(yī)藥原料及中間體,氨基酸鹽酸鹽

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:張京昂
  • 電話:027-59262863
  • 傳真:027-83309872
  • QQ:772370383
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 供應(yīng)苯海拉明
供應(yīng)苯海拉明
單價 面議對比
詢價 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
過期 長期有效
更新 2011-11-22 10:30
 
詳細(xì)信息

苯海拉明
產(chǎn)品類別 藥物中間體
分子式:C17H21NO·HCl
分子量:291.82
CAS編號 147-24-0
產(chǎn)品含量 98% 
包裝規(guī)格 25KG桶
質(zhì)量標(biāo)準(zhǔn) CPBP醫(yī)藥級
產(chǎn)品說明 白色結(jié)晶性粉末,折光:1.546-1.552 。DMEA:<0.9% 。比重:1.013-1.02 
          
用途:用于抗過敏,暈動癥。皮膚粘膜過敏,如蕁麻疹、血管神經(jīng)性水腫、過敏性鼻炎,其他皮膚瘙癢癥、藥疹、接觸性皮炎。

©2025 武漢大華偉業(yè)醫(yī)藥化工有限公司供應(yīng)部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7339  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |